跳至主要内容
临床试验/ISRCTN68578366
ISRCTN68578366已完成不适用

Topical (intra-articular) TRANeXamic acid reduces blood loss and transfusion rates following total Knee replacement: a randomised controlled trial

niversity Hospital of North Tees and Hartlepool (UK)0 个研究点目标入组 150 人开始时间: 2012年4月30日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Undergoing unilateral primary cemented total knee replacement

排除标准

  • 1. Undergoing unilateral primary total knee replacement for trauma or tumour
  • 2. Allergic to tranexamic acid
  • 3. Bleeding tendency (e.g. Haemophilic and platelets disorders)
  • 4. Warfarin, treatment dose of low molecular weight heparin (LMWH) or conventional heparin
  • 5. History of deep vein thrombosis (DVT) and pulmonary embolism
  • 6. Renal failure with creatinine > 250 micromole/l
  • 7. Female subjects of child bearing potential must have a negative pregnancy test

研究者

发起方
niversity Hospital of North Tees and Hartlepool (UK)

相似试验

Topical TRANeXamic acid in total Knee replacement | 临床试验